MedTrace Logo

Predicting Functional Outcome and Response to Therapy of Anti-NMDAR Encephalitis at Diagnosis

NCT06023160 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 714

Last updated 2025-03-04

No results posted yet for this study

Summary

The goal of this international cohort study is to develop a prediction model for long-term outcome and response to first-line immunotherapy of anti-NMDAR Encephalitis, already at the moment of diagnosis.

Conditions

  • Anti-NMDA (N-Methyl D-Aspartate) Receptor Encephalitis

Sponsors & Collaborators

Principal Investigators

  • Maarten J. Titulaer, Assoc. Porf. · Erasmus Medical Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2023-07-01
Completion
2024-07-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06023160 on ClinicalTrials.gov